Market Overview

The Global Escherichia Coli Testing Market was valued at USD 2,363.0 million in 2023 and is expected to reach USD 4,605.8 million by 2031 while growing at a CAGR of 8.7% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global Escherichia Coli Testing market growth. Escherichia coli (E. coli) Testing identifies this Gram-negative bacteria in clinical, food, and environmental samples. It resides in human and animal inTestines, with some strains causing mild to severe illnesses, including gastroinTestinal infections, urinary tract infections, and foodborne illnesses.

The rising cases of foodborne illnesses, along with advancements in E. coli Testing tech like rapid detection and molecular diagnostics, boost the E. coli Testing market. Yet, certain factors hinder its growth.

Furthermore, the global Escherichia Coli Testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Test Analysis

The Global Escherichia Coli Testing Market is segmented among Clinical Testing, and Environmental Testing, based on Test. In 2023, Clinical Testing accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Escherichia Coli Testing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Becton, Dickinson and Company, Bio-Rad Laboratories Inc, Caisson Laboratories, Inc, Cell Culture Technologies LLC, Corning Incorporated, Fujifilm Holdings Corporation, GE Healthcare, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, and Merck & Co., Inc

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Escherichia Coli Testing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Escherichia Coli Testing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Escherichia Coli Testing Market Segmentation, By Test

• Global Escherichia Coli Testing Market Share Analysis, By Test

• Global Escherichia Coli Testing Market Growth Analysis, By Test

• Global Escherichia Coli Testing Market Trends, By Test

o Clinical Testing

Ø Polymerase Chain Reaction

Ø Enzyme Immunoassays

o Environmental Testing

Ø Membrane Filtration

Ø Multiple Tube Fermentation

Ø Enzyme Substrate Method

6. Global Escherichia Coli Testing Market Segmentation, By Region

• Global Escherichia Coli Testing Market Share Analysis, By Region

• Global Escherichia Coli Testing Market Growth Analysis, By Region

• Global Escherichia Coli Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

7. Competitive Landscape

• Becton, Dickinson and Company*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Bio-Rad Laboratories Inc

• Caisson Laboratories, Inc

• Cell Culture Technologies LLC

• Corning Incorporated

• Fujifilm Holdings Corporation

• GE Healthcare

• HiMedia Laboratories Pvt., Ltd

• Lonza Group Ltd

• Merck & Co., Inc

*Similar analysis will be provided for each company listed above.